Cypre's blog to discuss the latest movements in science.
Our collaborators at Charles River have launched the joint service offering through their website, combining the CRL Tumor Model Compendium (PDX in vitro, ex vivo, cell lines) with Cypre’s 3D Tumor Model Platform to deliver translationally relevant 3D assays for cancer drug discovery.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
